Previous Close | 32.91 |
Open | 32.85 |
Bid | 32.61 x 51100 |
Ask | 32.63 x 25600 |
Day's Range | 32.61 - 32.89 |
52 Week Range | 21.14 - 35.30 |
Volume | |
Avg. Volume | 2,320,185 |
Market Cap | 48.648B |
Beta (5Y Monthly) | 0.67 |
PE Ratio (TTM) | 32.96 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 0.30 (0.90%) |
Ex-Dividend Date | May 08, 2024 |
1y Target Est | N/A |
Hologic's (HOLX) GYN Surgical Q2 performance was driven by strong results from MyoSure and Fluent Fluid Management.
Lantheus' (LNTH) robust revenues from the majority of its segments drive its first-quarter performance.
Bruker's (BRKR) BioSpin segment witnessed growth across biopharma, academic government and industrial research in the first quarter of 2024.